Blue Leaf Ventures Competitors

PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders. For more information, visitwww.puretechhealth.comor connect with us on X (formerly Twitter) @puretechh.

Flourish is an early-stage global venture capital firm that backs entrepreneurs whose innovations advance financial health and prosperity for individuals and small businesses. Founded in 2019, Flourish has $500M under management and deploys patient capital with a long-term perspective, partnering with fintech founders and industry thought leaders in research, and policy to help foster a fair, more inclusive economy. For more information, visit: www.flourishventures.com

SJF Ventures invests in high-growth companies creating a healthier, smarter and cleaner future. Our mission is to catalyze the development of highly successful businesses driving lasting, positive changes. We are experienced venture capital investors who have been at the forefront of impact investing since 1999. We are passionate about generating extraordinary results, creating positive changes, and partnering with visionaries who combine these two. Our team has invested in over 50 ventures, bringing time-tested perspective and expertise to partnerships with entrepreneurs. We are ready and eager to build something special together. SJF Ventures has offices in Durham, New York, San Francisco and Seattle. Through its investment funds, the firm provides equity financings from $1MM to $10MM, solo or in syndicates, to companies seeking growth capital.